News
CaroSpir, a Liquid Form of Spironolactone, Now Available in Unit Dose Cups
The new packaging allows for ease of administration and convenience.
Your search for Spironolactone returned 24 results
News
Hyponatremia in Heart Failure Linked to High-Dose Furosemide, Spironolactone
In an observational study, furosemide doses of 250 to 500 mg and spironolactone doses of 50 to 100 mg were independently associated with approximately 14% and 20% increased odds of hyponatremia, respectively.
News
Spironolactone Use Associated With Reduced Prostate Cancer Risk
Men who had ever used spironolactone had decreased odds of prostate cancer compared with never-users, according to a study.
News
FDA-Approved Spironolactone Oral Suspension Now Available
First FDA-approved oral liquid dosage form of the potassium-sparing diuretic spironolactone.
ESC 2017
Spironolactone and Amiloride Effective in Drug-Resistant Hypertension
Several sub-studies investigated the superior efficacy of spironolactone in RHTN and whether there was potential benefit with amiloride in the same population.
News
FDA Approves CaroSpir, an Oral Suspension Formulation of Spironolactone
CaroSpir, an aldosterone antagonist, works primarily through competitive binding of receptors at the aldosterone-dependent sodium-potassium exchange site in the distal convoluted renal tube.
ACC.17
Real-World Efficacy of Spironolactone in Hospitalized HFrEF Patients
Among eligible patients with heart failure and reduced ejection fraction (HFrEF), use of spironolactone was associated with improved clinical outcomes.
News
Heart Failure With Mildly Reduced Ejection Fraction: Treatment Options Explored
Despite an increasing emphasis on HFmrEF over the past several years, there is a lack of authoritative guidance surrounding therapeutic approaches for these patients.
News, Urological Disorders
Study IDs Meds Commonly Used in Primary Care That Should Be Dose Adjusted, Avoided in CKD
A list of medications routinely prescribed in primary care practice that should be used cautiously or avoided in patients with chronic kidney disease (CKD) was compiled in a recently published study in the Annals of Pharmacotherapy.
News
Slynd, a Progestin-Only Contraceptive, Now Available
Exeltis USA announced the commercial launch of Slynd (drospirenone), which is indicated for use by females of reproductive potential to prevent pregnancy. Slynd is a progestin-only contraceptive that lowers the risk of becoming pregnant primarily by suppressing ovulation. It contains the synthetic progestin drospirenone in a 4mg dosage strength that is given in a 24/4…
